Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis

Cansu B., Cansu D. U., Kasifoglu T., Gulbas Z., Korkmaz C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.17, no.1, pp.14-17, 2011 (SCI-Expanded) identifier identifier identifier


Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).